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Editorial
In search for optimal results for transcatheter aortic valve-in-valve procedures
Em busca de resultados ótimos para procedimentos transcateter aórticos valve-in-valve
The valve-in-valve procedure consists of the transcatheter im-
plantation of a valve within a failed bioprosthetic surgical valve 
and was first carried out in 2007, by Wenaweser et al.,1 in a patient 
with severe aortic regurgitation caused by surgical bioprosthesis 
degeneration. Since then, this type of treatment has experienced 
an increase in use, expanding its range of indications for the treat-
ment of failed bioprosthesis implanted in non-aortic positions and 
becoming an alternative for selected patients. Although the proce-
dure is similar to that of transcatheter implantation in native 
valves, there are differences that require attention.
In this issue, we present the study of Meneguz-Moreno et al., 
from Instituto Dante Pazzanese de Cardiologia and Hospital do 
Coração (São Paulo, SP), on the initial experience with valve-in-valve 
procedures, using the self-expanding CoreValve system or the bal-
loon-expandable SAPIEN XT system in patients with failed aortic 
bioprosthesis. The article describes all the steps of the pre-clinical 
evaluation, with emphasis on the characteristics of the surgical 
prosthesis, especially its internal diameter, and the ideal valve-in-
valve implantation depth. It also contains, in detail, the characteris-
tics of the procedure and the clinical and hemodynamic outcomes at 
30 days and 1 year. In a related editorial, Simonato, Rana, and Dvir, 
from Saint Paul's Hospital (Vancouver, Canada), remind us that the 
number of degenerated bioprostheses has been increasing over time 
and that surgical replacement of the failed prosthesis is still the first 
therapeutic option, but there is a strong appeal for minimally-inva-
sive procedures. They acknowledge the limitations of valve-in-valve 
interventions, particularly the occurrence of a post-procedure ele-
vated gradient (> 20 mmHg) in up to one-third of cases, and its asso-
ciation with a worse prognosis, highlighting their predictors 
(surgical valve stenosis and the transcatheter valve model used), 
recommending the implantation depth of the CoreValve and SAPIEN 
XT prostheses to prevent this phenomenon.  
Another article worth mentioning that has an important contri-
bution to the endovascular area is the study by Metzger et al., also 
from Instituto Dante Pazzanese de Cardiologia. These authors show 
the in-hospital and medium-term outcomes in patients with athero-
sclerotic lesions in the superficial femoral artery treated with 
third-generation superflexible stents. Interventions in this territory 
remain a challenge for interventionists due to compression, flexion, 
twisting, and rotational forces exerted by muscle compartments on 
the vessel wall, which can lead to stent fracture, with consequent 
prosthesis restenosis and occlusion. Freitas, Pitta, and Scheinert, 
from the University of Leipzig (Leipzig, Germany), in a correspond-
ing editorial, summarize the main aspects of peripheral artery dis-
ease, drawing attention to its impact on quality of life and the 
current importance of endovascular interventions, which outweigh 
the number of surgical corrections in many specialized centers. 
They further call attention on the significant reduction of amputa-
tions in patients with critical lower-limb ischemia, the promising 
results of the latest generation of stents, and the need for random-
ized studies comparing the different available technical solutions.
Still within the field of structural heart disease interventions, 
Chamié et al., from Hospital Federal dos Servidores do Estado (Rio de 
Janeiro, RJ), demonstrate the results of percutaneous occlusion of 
the left atrial appendage in patients with atrial fibrillation and con-
traindications or complications associated with oral anticoagula-
tion. The authors describe the procedure steps in detail, taking into 
account access to the left atrium, the anatomical analysis of the ap-
pendage and its variable morphology, the correct sizing of the pros-
thesis, and the characteristics of a significant periprosthetic residual 
flow. Additionally, they explain the strategy for dealing with a par-
ticularly challenging case of the series and present the results of me-
dium-term patient follow-up.
This issue also features other articles of great interest, such as the 
early and late outcomes of patients undergoing percutaneous mitral 
valvuloplasty in a center with an intermediate volume of proce-
dures, several topics related to percutaneous treatment of coronary 
disease, the results of ductal stenting in newborns and infants, and 
the results of interatrial septal defect occlusion guided by intravas-
cular ultrasound.
Finally, we would like to highlight the contribution of Iberian 
countries to this edition, with case report and images in cardiovas-
cular intervention from Hospital Clínico San Carlos (Madrid, Spain), 
Centro Hospitalar de Trás-os-Montes e Alto Douro (Vila Real, Portu-
gal), and Hospital Dr. Nélio Mendonça (Funchal, Portugal).  
Enjoy your reading!
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